文献速递脊柱关节炎

抑郁症状对中轴型脊柱关节炎患者治疗应答的影响:来自RABBIT-SpA登记研究的数据

Effect of depressive symptoms on treatment response in patients with axSpA: data from the RABBIT-SpA register.
PubMed 文献 · RMD Open · 2025-05-08

基于RABBIT-SpA纵向观察性登记研究1755例中轴型脊柱关节炎患者,采用WHO-5幸福感指数量表评估抑郁症状(评分低于29分提示中重度症状),分析基线抑郁症状与新系统治疗后3个月和6个月低疾病活动度(LDA)及非活动性疾病(ID)的关系。结果显示29%的患者基线存在中重度抑郁症状,伴中重度抑郁症状者达到LDA或ID的比例低于无或轻度症状者,逻辑回归分析显示抑郁症状与两个时间点达到LDA或ID的较低比值比相关。

要点

  • 29%的中轴型脊柱关节炎患者基线存在中重度抑郁症状(WHO-5评分低于29分)。
  • 伴中重度抑郁症状者治疗后3个月和6个月达到LDA或ID的比例低于无或轻度症状者。
  • 逻辑回归分析显示抑郁症状与达到LDA或ID的较低比值比相关。

核心结论

  • 抑郁症状对中轴型脊柱关节炎患者的治疗应答具有显著且独立的负面影响,尤其体现在达到低疾病活动度和非活动性疾病方面。

研究设计与样本

  • 本研究为纵向观察性RABBIT-SpA登记研究分析,共纳入1755例中轴型脊柱关节炎患者。
  • 抑郁症状采用WHO-5幸福感指数量表评估,评分低于29分提示中重度症状。
  • 治疗结局低疾病活动度和非活动性疾病基于C反应蛋白校正的中轴型脊柱关节炎疾病活动度评分,于新系统治疗开始后3个月和6个月评估。
  • 采用经有向无环图选择混杂变量的逻辑回归模型评估基线抑郁症状与治疗结局的关系,并用多重插补处理缺失数据。

主要发现

  • 基线时29%的患者存在中重度抑郁症状。
  • 与无或轻度抑郁症状患者相比,伴中重度抑郁症状者在3个月和6个月达到低疾病活动度或非活动性疾病的比例更低。
  • 逻辑回归分析显示,抑郁症状与两个时间点达到低疾病活动度或非活动性疾病的较低比值比相关。

临床怎么用

  • 作者认为,这些发现强调在中轴型脊柱关节炎管理中常规进行心理健康筛查并治疗抑郁症状对优化疾病结局的重要性。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: This analysis aimed to evaluate the effect of depressive symptoms on treatment outcomes in patients with axial spondyloarthritis (axSpA), focusing on low disease activity (LDA) and inactive disease (ID) at 3 and 6 months after the start of a new systemic therapy. METHODS: This analysis used data from the longitudinal, observational RABBIT-SpA register. Depressive symptoms were assessed using the WHO-5 Well-Being Index, with scores below 29 indicating moderate-to-severe symptoms. The treatment outcomes LDA and ID, based on the Axial Spondyloarthritis Disease Activity Score with C-reactive protein, were evaluated after 3 and 6 months. Logistic regression models adjusted for confounding variables, selected via a directed acyclic graph, were used to assess the relationship between baseline depressive symptoms and treatment outcomes. Multiple imputation was used to handle missing data. RESULTS: A total of 1755 patients with axSpA were included in the analysis. Moderate-to-severe depressive symptoms were present in 29% of patients at baseline. Fewer patients with moderate-to-severe depressive symptoms reached LDA or ID at 3 months and 6 months compared with those with no or mild symptoms. Logistic regression analysis showed that depressive symptoms were associated with lower odds of reaching LDA or ID at both time points. CONCLUSION: Depressive symptoms have a significant and independent negative effect on treatment response in patients with axSpA, particularly in achieving LDA and ID. These findings highlight the importance of routine mental health screening and treatment of depressive symptoms in axSpA management to optimise disease outcomes.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Reich A, Weiß A, Lindner L, et al. Effect of depressive symptoms on treatment response in patients with axSpA: data from the RABBIT-SpA register. RMD Open. 2025. PMID: 40345709. doi:10.1136/rmdopen-2025-005422

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。